Evolv Technologies Holdings Reports Strongest Quarter in Two Years, Sets Ambitious 2026 Outlook

The information‑technology specialist has confirmed a remarkable rebound in revenue and customer acquisition, positioning itself for accelerated growth through 2026. On August 12, 2026, the company announced a 34 % surge in Q2 revenue to $43.8 million, surpassing the analyst consensus by $1.99 million. The figure represents the highest quarterly earnings in two years and signals a sustained upward trajectory for the firm.

Q2 Highlights

  • Revenue: $43.8 million, up 34 % YoY, and above estimates by nearly $2 million.
  • Non‑GAAP EPS: a modest -$0.02 that remained in line with expectations, reflecting the company’s continued investment in expansion rather than short‑term profitability.
  • New customer additions: the firm logged its strongest quarterly count in two years, underscoring the robust demand for its AI‑powered touch‑less screening solutions.
  • Deployments: the company projects over 10,000 units in service by the end of 2026, a target that aligns with its broader ambition of expanding global market penetration.

Analyst Reaction

Leading research houses quickly followed the announcement. Craig‑Hallum lifted its price target on both Investing.com and de.investing.com, citing the company’s “strong Q2 results” as a catalyst for the upward revision of its full‑year 2026 outlook. The brokerage noted that the revenue bump, coupled with the firm’s aggressive deployment strategy, justifies a higher valuation multiple.

Forward‑Looking Outlook

Evolv’s management reiterated its guidance for 2026, projecting $180 million to $185 million in annual revenue. The guidance is underpinned by an aggressive push to expand the installed base and by the continued deployment of the company’s proprietary AI screening platform across diverse sectors—defense, aviation, and public health. The firm’s strategic focus on touch‑less, AI‑driven detection is expected to secure recurring revenue streams as global security demands rise.

Market Context

The company’s share price, trading at $5.72 on August 11, 2026, sits roughly 36 % below its 52‑week high of $8.91 and 15 % above its 52‑week low of $4.865. With a market capitalization of $1.03 billion, the stock remains relatively modest compared to its peers, potentially offering upside if the company sustains its growth momentum.

Conclusion

Evolv Technologies Holdings has demonstrated that its AI‑powered screening portfolio is resonating with customers worldwide. The combination of robust quarterly performance, an ambitious deployment target, and a revised full‑year outlook suggests the company is well positioned to capture a larger share of the growing security and health‑tech market. Investors watching the sector should keep a close eye on how the company translates its deployment milestones into sustained revenue and profitability.